Request to Join
has invited you to join this group
James J. Driscoll, MD, PhD received his B.A. in Biology and PhD in Biochemistry from the State University of New York at Buffalo. He then completed his MD degree, served as an intern and resident in Internal Medicine (Boston University Medical Center) and completed training in the Combined Hematology and Oncology Fellowship Program at the National Cancer Institute in Bethesda, MD. Dr. Driscoll has also pursued a postdoctoral fellowship at Harvard Medical School and the Veterans Affairs Boston Healthcare System investigating the role of the ubiquitin+proteasome system in multiple myeloma. He joined the Division of Hematology & Oncology at the University of Cincinnati College of Medicine in 2011 as an Assistant Professor. The focus of his research has been understanding the molecular mechanisms responsible for resistance to proteasome inhibitors as well as the genetic bases for patient response to proteasome inhibitors. In addition to his laboratory interests, Dr. Driscoll teaches graduate students and Hematology & Oncology Fellows on the faculty of the University of Cincinnati Medical School. He was recently selected to serve on NIH Study Sections, the American Society of Hematology Advocacy Leadership Institute and the Multiple Myeloma Think Tank for the Integration of Novel Targets for Therapy.